Konruns(SH:603590) Zhong Guo Jing Ji Wang·2025-10-21 03:17Core Viewpoint - Kangchen Pharmaceutical (603590.SH) announced a significant change in shareholder equity, with major shareholder Liu Jianhua reducing his stake by 1,911,900 shares, resulting in a decrease in ownership from 46.65% to 45.45% [1][3]. Shareholder Changes - Liu Jianhua sold a total of 1,911,900 shares through centralized bidding and block trading on October 20, 2025, reducing his holdings from 74,341,860 shares to 72,429,960 shares [1]. - The total cash raised from this transaction amounted to approximately 97.37 million yuan, based on an average share price of 50.93 yuan on the transaction date [2]. Shareholding Structure - Before the transaction, Liu Jianhua held 48,496,260 shares (30.43%), which decreased to 46,584,360 shares (29.23%) post-transaction [3]. - Other shareholders, such as Beijing Muren Investment Management Co., Ltd. and Beijing Puhua Jiyie Investment Consulting Center (Limited Partnership), maintained their respective holdings of 10.19% and 6.02% without any changes [3]. Company Background - Kangchen Pharmaceutical was listed on the Shanghai Stock Exchange on August 27, 2018, with an initial issuance of 40 million shares, accounting for 25% of the total share capital post-issuance [4]. - The company raised a total of 973.6 million yuan, with a net fundraising amount of approximately 891.43 million yuan, aimed at various projects including innovative drug research and development [4].